Development of a COVID-19 early risk assessment system based on multiple machine learning algorithms and routine blood tests: a real-world study.
Journal:
Frontiers in immunology
PMID:
39403385
Abstract
BACKGROUNDS: During the Coronavirus Disease 2019 (COVID-19) epidemic, the massive spread of the disease has placed an enormous burden on the world's healthcare and economy. The early risk assessment system based on a variety of machine learning (ML) algorithms may be able to provide more accurate advice on the classification of COVID-19 patients, offering predictive, preventive, and personalized medicine (PPPM) solutions in the future.